JP2008503591A5 - - Google Patents

Download PDF

Info

Publication number
JP2008503591A5
JP2008503591A5 JP2007518253A JP2007518253A JP2008503591A5 JP 2008503591 A5 JP2008503591 A5 JP 2008503591A5 JP 2007518253 A JP2007518253 A JP 2007518253A JP 2007518253 A JP2007518253 A JP 2007518253A JP 2008503591 A5 JP2008503591 A5 JP 2008503591A5
Authority
JP
Japan
Prior art keywords
alkyl
heteroaryl
mono
aryl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007518253A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008503591A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/022157 external-priority patent/WO2006002284A1/en
Publication of JP2008503591A publication Critical patent/JP2008503591A/ja
Publication of JP2008503591A5 publication Critical patent/JP2008503591A5/ja
Pending legal-status Critical Current

Links

JP2007518253A 2004-06-22 2005-06-22 ユビキチンリガーゼ阻害剤 Pending JP2008503591A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58226104P 2004-06-22 2004-06-22
US64610205P 2005-01-21 2005-01-21
PCT/US2005/022157 WO2006002284A1 (en) 2004-06-22 2005-06-22 Ubiquitin ligase inhibitors

Publications (2)

Publication Number Publication Date
JP2008503591A JP2008503591A (ja) 2008-02-07
JP2008503591A5 true JP2008503591A5 (enExample) 2008-08-14

Family

ID=34979690

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007518253A Pending JP2008503591A (ja) 2004-06-22 2005-06-22 ユビキチンリガーゼ阻害剤

Country Status (4)

Country Link
US (1) US20050282818A1 (enExample)
EP (1) EP1758873A1 (enExample)
JP (1) JP2008503591A (enExample)
WO (1) WO2006002284A1 (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1661889A4 (en) * 2003-09-05 2009-08-05 Ono Pharmaceutical Co ANTAGONIST OF THE CHEMOKINE RECEPTOR AND ITS USE FOR MEDICAL PURPOSES
EP1848718B1 (en) * 2005-02-04 2012-08-01 Millennium Pharmaceuticals, Inc. Inhibitors of e1 activating enzymes
WO2006105127A2 (en) * 2005-03-31 2006-10-05 Takeda San Diego, Inc. Hydroxysteroid dehydrogenase inhibitors
CN106008512B (zh) * 2006-02-02 2019-03-12 千禧药品公司 E1活化酶抑制剂
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
NZ574513A (en) * 2006-08-08 2012-02-24 Millennium Pharm Inc Heteroaryl compounds useful as inhibitors of e1 activating enzymes
AU2013203433B2 (en) * 2006-08-08 2016-07-28 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
WO2008115259A2 (en) * 2006-08-10 2008-09-25 Rigel Pharmaceuticals, Inc. Derivatives of benzoxadiazole suitable for the treatment of cell proliferative diseases
WO2008052441A1 (en) * 2006-11-02 2008-05-08 Lan Huang Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof
ES2304112B1 (es) * 2007-02-23 2009-08-13 Universidad De Zaragoza Uso de compuestos como inhibidores de la flavodoxina de helicobacter.
ES2304220B1 (es) * 2007-03-02 2009-09-11 Universidad De Zaragoza Composicion para el tratamiento de enfermedades infecciosas.
ES2304221B1 (es) * 2007-03-02 2009-09-11 Universidad De Zaragoza Composicion para el tratamiento de enfermedades infecciosas causadas por helicobacter.
WO2008124838A1 (en) * 2007-04-10 2008-10-16 University Of Maryland, Baltimore Compounds that inhibit human dna ligases and methods of treating cancer
CN101790526A (zh) * 2007-06-08 2010-07-28 雅培制药有限公司 用作激酶抑制剂的5-杂芳基取代的吲唑化合物
WO2009025854A1 (en) * 2007-08-22 2009-02-26 Burnham Institute For Medical Research Smips: small molecule inhibitors of p27 depletion in cancers and other proliferative diseases
GB0717982D0 (en) * 2007-09-14 2007-10-24 Univ Durham Method and means relating to multiple herbicide resistance in plants
CN102924412A (zh) * 2008-01-25 2013-02-13 先正达参股股份有限公司 用作杀虫剂的2-氰基苯基磺酰胺衍生物
US8673910B2 (en) * 2008-06-30 2014-03-18 H. Lee Moffitt Cancer Center And Research Institute Proteasome inhibitors for selectively inducing apoptosis in cancer cells
HRP20150355T1 (hr) 2009-01-12 2015-06-19 Pfizer Limited Sulfonamidni derivati
WO2010102286A2 (en) 2009-03-06 2010-09-10 H. Lee Moffitt Cancer Center And Research Institute, Inc. Proteasome inhibitors having chymotrypsin-like activity
WO2010128156A1 (en) * 2009-05-08 2010-11-11 Pike Pharma Gmbh 2,1,3-benzoxadiazol derivatives for the inhibition of influenza a and b virus and respiratory syncytial virus replication
CN102421780A (zh) 2009-05-14 2012-04-18 米伦纽姆医药公司 氨基磺酸((1s，2s，4r)-4-{4-[(1s)-2，3-二氢-1h-茚-1-基氨基]-7h-吡咯并[2，3-d]嘧啶-7-基}-2-羟基环戊基)甲酯盐酸盐
GB201007187D0 (en) 2010-04-29 2010-06-09 Iti Scotland Ltd Ubiquitination modulators
EP2590972B1 (en) 2010-07-09 2015-01-21 Pfizer Limited N-sulfonylbenzamides as inhibitors of voltage-gated sodium channels
EP2675275B1 (en) 2011-02-14 2017-12-20 The Regents Of The University Of Michigan Compositions and methods for the treatment of obesity and related disorders
MY166889A (en) 2011-08-24 2018-07-24 Millennium Pharm Inc Inhibitors of nedd8-activating enzyme
US9486422B2 (en) 2011-10-06 2016-11-08 The Regents Of The University Of Michigan Small molecule inhibitors of Mcl-1 and the uses of thereof
ES2396764B1 (es) * 2011-11-02 2013-12-19 Universidad Autónoma de Madrid FÁRMACOS INHIBIDORES DE p38 Y APLICACIONES.
UA116534C2 (uk) 2012-02-17 2018-04-10 Мілленніум Фармасьютікалз, Інк. Піразолопіримідинілові інгібітори убіквітинактивуючого ферменту
GB201212456D0 (en) 2012-07-12 2012-08-29 Univ Sheffield Treatment of muscular dystrophy
BR112015003824B1 (pt) * 2012-08-24 2022-10-04 Treventis Corporation Composto, composição farmacêutica e uso do composto
ES2727898T3 (es) 2013-05-02 2019-10-21 Univ Michigan Regents Amlexanox deuterado con estabilidad metabólica mejorada
CA2909964A1 (en) * 2013-05-02 2014-11-06 E3X Bio Method for identifying modulators of ubiquitin ligases
EA032577B1 (ru) 2013-07-02 2019-06-28 Милленниум Фармасьютикалз, Инк. Гетероарильные соединения, пригодные в качестве ингибиторов sumo-активирующего фермента
HRP20191150T1 (hr) 2014-02-27 2019-10-04 Treventis Corporation Antiamiloidni spojevi koji sadrže benzofuran
WO2015157382A1 (en) * 2014-04-11 2015-10-15 Emory University Treatment of neurodegenerative diseases with asparagine endopeptidase (aep) inhibitors and compositions related thereto
RS59474B1 (sr) 2014-07-01 2019-12-31 Millennium Pharm Inc Heteroarilna jedinjenja koja su korisna kao inhibitori sumo-aktivirajućeg enzima
EP3221299A1 (en) 2014-11-21 2017-09-27 BSIM2 Biomolecular Simulations Lda. 2-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof
EP3307723B1 (en) 2015-06-15 2020-11-11 BSIM2 - Biomolecular Simulations, S.A. Bis-furan derivatives as transthyretin (ttr) stabilizers and amyloid inhibitors for the treatment of familial amyloid polyneuropathy (fap)
US10214536B2 (en) 2016-01-29 2019-02-26 The Regents Of The University Of Michigan Amlexanox analogs
AU2017296289A1 (en) 2016-07-12 2019-01-31 Revolution Medicines, Inc. 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
CN106565694B (zh) * 2016-10-09 2019-10-15 北京化工大学 一种nbd-有机胺类荧光探针及其制备方法和应用
JP7240319B2 (ja) 2017-01-23 2023-03-15 レヴォリューション・メディスンズ，インコーポレイテッド アロステリックｓｈｐ２阻害剤としての二環式化合物
CN110431134A (zh) 2017-01-23 2019-11-08 锐新医药公司 作为变构shp2抑制剂的吡啶化合物
US10888564B2 (en) 2017-01-26 2021-01-12 Institute For Cancer Research Inhibitors of HIV-1 integrase multimerization
EP3694848A1 (en) 2017-10-12 2020-08-19 Revolution Medicines, Inc. Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitors
TW201927791A (zh) 2017-12-15 2019-07-16 美商銳新醫藥公司 作為變構shp2抑制劑的多環化合物
US20230103965A1 (en) * 2020-02-02 2023-04-06 Ramot At Tel-Aviv University Ltd. Novel activators of the lipidating transporter atp binding cassette protein type 1 (ab-ca1) and therapeutic uses thereof
CN113149930B (zh) * 2021-04-16 2022-09-02 天津大学 一种细胞糖转运通道抑制剂
CN113582940B (zh) * 2021-09-07 2022-05-20 四川大学华西医院 一类脂滴特异性荧光探针及其合成方法
WO2025117672A1 (en) * 2023-12-01 2025-06-05 Hotspot Therapeutics, Inc. Indazolyl-piperidine sulfonamides and related compounds and their use in therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9604926D0 (en) * 1996-03-08 1996-05-08 Sandoz Ltd Organic compounds
GB9622386D0 (en) * 1996-10-28 1997-01-08 Sandoz Ltd Organic compounds
DE10000739A1 (de) * 2000-01-11 2001-07-12 Merck Patent Gmbh Piperidin- und Piperazinderivate
DE10045599B4 (de) * 2000-09-15 2004-06-03 Wella Ag Haarfärbemittel auf der Basis von 4-Nitro-2,1,3-benzoxadiazol-Derivaten und dessen Verwendung als Farbstoff zum Färben von Haaren
WO2002030358A2 (en) * 2000-10-11 2002-04-18 Tularik Inc. Modulation of ccr4 function
JP2005511625A (ja) * 2001-11-14 2005-04-28 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング 向精神薬としてのピラゾール誘導体
GB0215650D0 (en) * 2002-07-05 2002-08-14 Cyclacel Ltd Bisarylsufonamide compounds
US20040157836A1 (en) * 2002-10-08 2004-08-12 Comess Kenneth M. Sulfonamides having antiangiogenic and anticancer activity
US7491718B2 (en) * 2002-10-08 2009-02-17 Abbott Laboratories Sulfonamides having antiangiogenic and anticancer activity
WO2005007621A2 (en) * 2003-05-30 2005-01-27 Rigel Pharmaceuticals, Inc. Ubiquitin ligase inhibitors
US20050130974A1 (en) * 2003-10-17 2005-06-16 Rigel Pharmaceuticals, Inc. Benzothiazole compositions and their use as ubiquitin ligase inhibitors

Similar Documents

Publication Publication Date Title
JP2008503591A5 (enExample)
JP7126541B2 (ja) ハンチントンタンパク質のイメージング用プローブ
JP7169412B2 (ja) 抗癌活性及び抗増殖活性を呈する２－アミノピリミジン－６－オン及び類似体
JP2016514719A5 (enExample)
JP2015522036A5 (enExample)
JP2015502387A5 (enExample)
JP2018534326A5 (enExample)
JP2018115201A5 (enExample)
JP2018529739A5 (enExample)
JP2016514718A5 (enExample)
JP2017511357A5 (enExample)
JP2014525432A5 (enExample)
JP2018519357A5 (enExample)
JP2015537017A5 (enExample)
RU2013151803A (ru) Бициклические гетероциклические соединения и их применения в терапии
JP2016525075A5 (enExample)
JP7244504B2 (ja) ＰＩ３Ｋ－γ阻害剤としての三級ヒドロキシ基で置換された縮合イミダゾール誘導体
JP2019521984A5 (enExample)
CA2651363A1 (en) Triazolopyrazine derivatives useful as anti-cancer agents
JP2016506368A5 (enExample)
JP2017528519A5 (enExample)
JP2017538721A5 (enExample)
JP2015529224A5 (enExample)
HRP20230472T1 (hr) Novi derivati hidroksikiseline, postupak njihove priprave i farmaceutski sastavi koji ih sadrže
JP2016531858A5 (enExample)